1[1]Ross R, Glomset J A. The pathogenesis of atherosclerosis [J]. N Engl J Med, 1976,295:369～377.
2[2]Ross R. Atherosclerosis: An inflammatory disease[J]. N Engl J Med, 1999,340:115～126.
3[3]Ridker P M, Hennekens C H, Starnpfer M J, et al.Prospective study of herpes simplex virus, cytomegalovims,and the risk of future myocardial infarction and stroke[ J ].Circulation, 1998,98:2796～2799.
4[4]Weber C, Erl W, Pietsch A, et al. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor- kappa B mobilization and induction of vascular cell adhesion molecule- 1 in endothelial cells stimulated to generate radicals[ J ]. Arterioscler Thromb, 1994,14:1665～ 1673.
5[5]Bhakdi S, Torzewski M, Klouche M, et al. Complement and atherosclerosis: Binding of CRP to degraded, nonoxidized LDL enhances complement activation[J ]. Arterioscler Thromb Vasc Biol, 1999,19:2354～2358.
6[6]Biasucci L M, Liuzzo G, Fantuzzi G, et al. Increasing levels of interleukin(IL) - 1Ra and IL- 6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in- hospital coronary events[J ]. Circulation,1999,99: 2079～ 2084.
7[7]Kockx M K, Knaapen MWM, Martinet W, et al. Expression of the uncoupling protein UCP - 2 in macrophages of unstable human atherosclerotic plaques [J ]. Circulation, 2000,102:11～12.
8[8]Casscells W, Hathorn B, David M, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: Possible implications for plaque rupture and thrombosis [ J ]. Lancet,1996,347:1447～1451.
9[9]Muller J E, Tofler G H, Stone P H. Circadian variation and triggers of onset of acute cardiovascular disease[ J ]. Circulation, 1989,79: 733～ 743.
10[10]Pasceri V, Chang J, Willerson J T, et al. Modulation of C- reactive protein - mediated monocyte chemoattractant protein- 1 induction in human endothelial cells by antiatherosclerosis drugs [ J ]. Circulation, 2001, 103:2531 ～2534.
